journal article·2022-01

Adsorptive removal of uremic toxins using Zr-based MOFs for potential hemodialysis membranes

Sen Zeng, Yaqi Hou, Yaming Zhou, Xi Zhou, Shefang Ye, Miao Wang, Lei Ren

Journal of Materials Science· Volume 57· Issue 4
Publisher page

Abstract

Protein-bound uremic toxins (PBUTs) are difficult to remove through dialytic procedures, and the accumulation of PBUTs is always associated with adverse symptoms in end-stage kidney disease. Hemoperfusions and novel membranes have been developed for the removal of PBUTs, but still suffer from low efficiency. Herein, we investigated the adsorption performance of three zirconium metal–organic frameworks (Zr-MOFs: UiO-66, UiO-66-SO3H, and UiO-66-(COOH)2) for two typical PBUTs (indoxyl sulfate, IS; hippuric acid, HA). We found that Zr-MOFs could adsorb PBUTs efficiently with a capacity of as high as 49.5 mg g−1 for IS and 38.3 mg g−1 for HA, respectively, due to the van der Waals interactions, Coulomb interactions, and π–π interactions. Density functional theory simulations demonstrated that H-bonding on basis of the –SO3H and –COOH groups could endow MOFs with better absorptivity. Further, to expand to practical hemodialysis applications, we incorporated Zr-MOFs into a polylactide (PLA) matrix to fabricate MOFs-based mixed matrix membranes (MMMs). The MMMs showed excellent in vitro biocompatibility and high water flux up to 260 L m−2 h−1. Under static conditions, the MMMs could remove HA and IS with a percentage of 75 and 78% in 4 h, respectively, whereas PLA membrane removed 12% of HA and 13% of IS. Under dynamic conditions, MMMs could remove 57% of IS and 54% of HA in 30 min; by contrast, PLA membrane only removed 2.9% of IS and 2.2% of HA. These MOFs-based MMMs with exceptional absorptivity, high water flux, and good biocompatibility might show great prospects in the foreground for the application of safe and efficient blood purification.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Membrane Separation Technologies · Membrane Separation and Gas Transport · Dialysis and Renal Disease Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Liabeuf S, Drüeke TB, Massy ZA (2011) Protein-bound uremic toxins: new insight from clinical studies. Toxins 3:911–91910.3390/toxins3070911 ↗
2. Vanholder R, Smet RD, Glorieux G, Argilés AA, Zidek W (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934–194310.1046/j.1523-1755.2003.00924.x ↗
3. Sun CY, Chang SC, Wu MS (2012) Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int 81:640–65010.1038/ki.2011.445 ↗
4. Vanholder R, Smet RD, Lameire N (2001) Protein-bound uremic solutes: the forgotten toxins. Kidney Int 59:266–27010.1046/j.1523-1755.2001.07805.x ↗
5. Tijink MS, Wester M, Glorieux G, Gerritsen KGF, Sun J, Swart PC, Borneman Z, Wessling M, Vanholder R, Joles JA (2013) Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma. Biomaterials 34:7819–782810.1016/j.biomaterials.2013.07.008 ↗
6. Li QS, Yang J, Cai N, Zhang JM, Xu T, Zhao WQ, Guo HS, Zhu YN, Zhang L (2019) Hemocompatible hemoadsorbent for effective removal of protein-bound toxin in serum. J Coll Interf Sci 555:145–15610.1016/j.jcis.2019.07.045 ↗
7. Yamamoto S, Sato M, Sato Y, Wakamatsu T, Takahashi Y, Iguchi A, Omori K, Suzuki Y, Ei I, Kaneko Y, Goto S, Kazama J, Gejyo F, Narita I (2017) Adsorption of protein-bound uremic toxins through direct hemoperfusion with hexadecyl-immobilized cellulose beads in patients undergoing hemodialysis: adsorption of protein-bound uremic toxins. Artif Org 42:88–9310.1111/aor.12961 ↗
8. Botella J, Ghezzi PM, Sanz-Moreno C (2000) Adsorption in hemodialysis. Kidney Int Suppl 76:S60-6510.1046/j.1523-1755.2000.07607.x ↗
9. Cheng YC, Fu CC, Hsiao YS, Chien CC, Juang RS (2018) Clearance of low molecular-weight uremic toxins p-cresol, creatinine, and urea from simulated serum by adsorption. J Mol Liq 252:203–21010.1016/j.molliq.2017.12.084 ↗
10. Grylewicz A, Mozia S (2021) Polymeric mixed-matrix membranes modified with halloysite nanotubes for water and wastewater treatment: a review. Sep Purif Technol 256:11782710.1016/j.seppur.2020.117827 ↗
11. Dechnik J, Gascon J, Doonan CJ, Janiak C, Sumby CJ (2017) New directions for mixed-matrix membranes. Angew Chem Int Edit 56:9292–931010.1002/anie.201701109 ↗
12. Geremia I, Bansal R, Stamatialis D (2019) In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma. Acta Biomater 90:100–11110.1016/j.actbio.2019.04.009 ↗
13. Abidina MNA, Goha PS, Saida N, Ismaila AF, Othmana MHD, Abdullaha MS, Nga BC, Hasbullaha H, Kadirb SH, Kamalb F, Mansur S (2020) Polysulfone/amino-silanized poly(methyl methacrylate) dual layer hollow fiber membrane for uremic toxin separation. Sep Purif Technol 236:11621610.1016/j.seppur.2019.116216 ↗
14. Fu CC, Hsiao YS, Ke JW, Syu WL, Liu TY, Liu SH, Juang RS (2020) Adsorptive removal of p-cresol and creatinine from simulated serum using porous polyethersulfone mixed-matrix membranes. Sep Purif Technol 245:11688410.1016/j.seppur.2020.116884 ↗
15. Jin E, Lee S, Kang EY, Kim Y, Choe WY (2020) Metal-organic frameworks as advanced adsorbents for pharmaceutical and personal care products. Coordin Chem Rev 425:21352610.1016/j.ccr.2020.213526 ↗
16. Rego RM, Kuriya G, Kurkuri MD, Kigga M (2021) MOF based engineered materials in water remediation: recent trends. J Hazard Mater 403:12360510.1016/j.jhazmat.2020.123605 ↗
17. Sai T, Ran SY, Guo ZH, Fang ZP (2019) A Zr-based metal-organic frameworks towards improving fire safety and thermal stability of polycarbonate. Compos Part B Eng 176:107198.1-107198.1010.1016/j.compositesb.2019.107198 ↗
18. Kato S, Otake KI, Chen H, Akpinar I, Buru CT, Islamoglu T, Snurr RQ, Farha QK (2019) Zirconium-based metal-organic frameworks for the removal of protein-bound uremic toxin from human serum albumin. J Am Chem Soc 141:2568–257610.1021/jacs.8b12525 ↗
19. Li Q, Zhao W, Guo H, Yang J, Zhang J, Liu M, Xu T, Chen Y, Zhang L (2020) Metal-organic framework traps with record-high bilirubin removal capacity for hemoperfusion therapy. ACS Appl Mater Interfaces 12:25546–2555610.1021/acsami.0c03859 ↗
20. CuChiaro H, Thai J, Schaffner N, Tuttle RR, Reynolds M (2020) Exploring the parameter space of p-cresyl sulfate adsorption in metal-organic frameworks. ACS Appl Mater Interf 12:22572–2258010.1021/acsami.0c04203 ↗
21. Qian S, Xia L, Yang LF, Wang XB, Suo XL, Xing HB (2020) Defect-free mixed-matrix membranes consisting of anion-pillared metal-organic frameworks and poly(ionic liquid)s for separation of acetylene from ethylene. J Membr Sci 611:11832910.1016/j.memsci.2020.118329 ↗
22. Chang X, Yang XF, Qiao Y, Wang S, Zhang MH, Xu J, Wang DH, Bu XH (2020) Confined heteropoly blues in defected Zr-MOF (bottle around ship) for high-efficiency oxidative desulfurization. Small 16:190643210.1002/smll.201906432 ↗
23. Zhang F, Hu X, Roth EW, Kim Y, Nguyen ST (2020) Template-assisted, seed-mediated synthesis of hierarchically mesoporous core-shell uio-66: enhancing adsorption capacity and catalytic activity through iterative growth. Chem Mater 32:4292–430210.1021/acs.chemmater.0c01065 ↗
24. Chen D, Yang W, Jiao L, Li L, Yu SH, Jiang HL (2020) Boosting catalysis of Pd nanoparticles in MOFs by pore wall engineering: the roles of electron transfer and adsorption energy. Adv Mater 32:200004110.1002/adma.202000041 ↗
25. Gao A, Liu F, Xue L (2014) Preparation and evaluation of heparin-immobilized poly (lactic acid) (PLA) membrane for hemodialysis. J Membr Sci 452:390–39910.1016/j.memsci.2013.10.016 ↗
26. Nie CX, Ma L, Xia Y, He C, Deng J, Wang LR, Cheng C, Sun S, Zhao C (2015) Novel heparin-mimicking polymer brush grafted carbon nanotube/PES composite membranes for safe and efficient blood purification. J Membr Sci 475:455–46810.1016/j.memsci.2014.11.005 ↗
27. Denny J, Cohen S (2015) In situ modification of metal-organic frameworks in mixed-matrix membranes. Angew Chem Int Ed Engl 54:9029–903210.1002/anie.201504077 ↗
28. Abdelhameed RM, Rehan M, Emam HE (2018) Figuration of Zr-based MOF@cotton fabric composite for potential kidney application. Carbohyd Polym 195:460–46710.1016/j.carbpol.2018.04.122 ↗
29. Liu YH, Peng XY, Hu ZD, Yu MG, Fu JJ, Huang YG (2021) Fabrication of a novel nitrogen-containing porous carbon adsorbent for protein-bound uremic toxins removal. Mat Sci Eng C-Mater 121:11187910.1016/j.msec.2021.111879 ↗
30. Lefebvre C, Rubez G, Khartabil H, Boisson J, Contreras-García J, Hénon E (2017) Accurately extracting the signature of intermolecular interactions present in the NCI plot of the reduced density gradient versus electron density. Phys Chem Chem Phys 19:17928–1793610.1039/C7CP02110K ↗
31. Lu T, Chen F (2012) Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem 33:580–59210.1002/jcc.22885 ↗
32. Ding L, Shao P, Luo Y, Yin X, Yu S, Fang L, Yang L, Yang J, Luo X (2020) Functionalization of UiO-66-NH2 with rhodanine via amidation: towarding a robust adsorbent with dual coordination sites for selective capture of Ag(I) from wastewater. Chem Eng J 382:12300910.1016/j.cej.2019.123009 ↗
33. Liu X, Demir N, Wu Z, Li K (2015) Highly water-stable zirconium metal-organic framework UiO-66 membranes supported on alumina hollow fibers for desalination. J Am Chem Soc 137:6999–700210.1021/jacs.5b02276 ↗
34. Zhuang S, Wang J (2021) Adsorptive removal of pharmaceutical pollutants by defective metal-organic framework UiO-66: insight into the contribution of defects. Chemosphere 281:13099710.1016/j.chemosphere.2021.130997 ↗
35. Lu L, Yeow J (2017) An adsorption study of indoxyl sulfate by zeolites and polyethersulfone–zeolite composite membranes. Mater Des 120:328–33510.1016/j.matdes.2017.01.094 ↗
36. Pavlenko D, Giasafaki D, Charalambopoulou G, VanGefen E, Gerritsen K, Steriotis T, Stamatialis D (2017) Carbon adsorbents with dual porosity for efficient removal of uremic toxins and cytokines from human plasma. Sci Rep 7:1491410.1038/s41598-017-15116-y ↗
37. Chen CQ, Chen DZ, Xie SS, Quan HY, Luo XB, Guo L (2017) Adsorption behaviors of organic micropollutants on zirconium metal-organic framework UiO-66: analysis of surface interactions. ACS Appl Mater Interf 9:41043–4105410.1021/acsami.7b13443 ↗
38. Sun WL, Li HB, Li HM, Li S, Cao XQ (2019) Adsorption mechanisms of ibuprofen and naproxen to UiO-66 and UiO-66-NH2: Batch experiment and DFT calculation. Chem Eng J 360:645–65310.1016/j.cej.2018.12.021 ↗
39. Li SS, Xie Y, Xiang T, Ma L, He C, Sun SD, Zhao CS (2016) Heparin-mimicking polyethersulfone membranes-hemocompatibility, cytocompatibility, antifouling and antibacterial properties. J Membr Sci 498:135–14610.1016/j.memsci.2015.09.054 ↗
40. Su NC, Sun DT, Beavers CM, Britt DK, Queen WL, Urban JJ (2016) Enhanced permeation arising from dual transport pathways in hybrid polymer-MOF membranes. Energ Environ Sci 9:922–93110.1039/C5EE02660A ↗
41. Mi YF, Xu G, Guo YS, Wu B, An QF (2020) Development of antifouling nanofiltration membrane with zwitterionic functionalized monomer for efficient dye/salt selective separation. J Membr Sci 601:11779510.1016/j.memsci.2019.117795 ↗
42. Chi C, Sun BH, Zhou NL, Zhang M, Chu XH, Yuan P, Shen J (2018) Anticoagulant polyurethane substrates modified with poly (2-methacryloyloxyethyl phosphorylcholine) via SI-RATRP. Coll Surf B 163:301–30810.1016/j.colsurfb.2018.01.005 ↗
43. Paluck S, Maynard H (2017) Structure activity relationship of heparin mimicking polymer p(SS-co-PEGMA): effect of sulfonation and polymer size on FGF2-receptor binding. Polym Chem 8:4548–455610.1039/C7PY00861A ↗
44. Cheng HJ, Liu YF, Hu YH, Ding YB, Lin SC, Cao W, Wang Q, Wu J, Muhammad F, Zhao XZ (2017) Monitoring of heparin activity in live rats using metal-organic framework nanosheets as peroxidase mimics. Anal Chem 89:11552–1155910.1021/acs.analchem.7b02895 ↗
45. Wu MX, Yang YW (2017) Metal-organic framework (MOF)-based drug/cargo delivery and cancer therapy. Adv Mater 29:160613410.1002/adma.201606134 ↗